Skip to main content
Journal of Microbiology and Biotechnology logoLink to Journal of Microbiology and Biotechnology
. 2022 Oct 31;33(2):143–150. doi: 10.4014/jmb.2210.10014

The Effects of Protein and Supplements on Sarcopenia in Human Clinical Studies: How Older Adults Should Consume Protein and Supplements

Young Jin Jang 1,*
PMCID: PMC9998208  PMID: 36474318

Abstract

Sarcopenia is a condition in which muscle mass, strength, and performance decrease with age. It is associated with chronic diseases such as diabetes, cardiovascular disease, and hypertension, and contributes to an increase in mortality. Because managing sarcopenia is critical for maintaining good health and quality of life for the elderly, the condition has sparked concern among many researchers. To counteract sarcopenia, intake of protein is an important factor, while a lack of either protein or vitamin D is a major cause of sarcopenia. In addition, essential amino acids, leucine, β-hydroxy β-methylbutyrate (HMB), creatine, and citrulline are used as supplements for muscle health and are suggested as alternatives for controlling sarcopenia. There are many studies on such proteins and supplements, but it is necessary to actually organize the types, amounts, and methods by which proteins and supplements should be consumed to inhibit sarcopenia. In this study, the efficacy of proteins and supplements for controlling sarcopenia according to human clinical studies is summarized to provide suggestions about how the elderly may consume proteins, amino acids, and other supplements.

Keywords: Sarcopenia, protein, whey, amino acids, leucine, HMB

Introduction

Sarcopenia is age-related loss of skeletal muscle mass and strength [1]. This disorder is associated with increased risk of falls and fractures, and it is also related to obesity and the development of insulin resistance, hypertension, diabetes, and cardiovascular disease [2]. The elderly with sarcopenia are more likely to have new depression symptoms than the non-sarcopenic elderly [3]. Several studies have shown that sarcopenia is associated with a significantly higher risk of mortality in adults and older adults [4, 5]. Moreover, risk of mortality was especially and directly related to strength in males older than 60 years. Rate of loss of strength was an important factor in mortality in those younger than 60 [6]. Therefore, sarcopenia was formally recognized as a disease and given the code ICD-10-CM (M62.84) in 2016 [7].

Various factors are involved in the onset and progression of sarcopenia. Lifestyle–related problems such as low physical activity, obesity, and smoking increase the risk of sarcopenia [8]. Nutrition factors such as low protein intake and calorie and vitamin D deficiency are also main causes of sarcopenia [8]. Chronic inflammation also affects sarcopenia, as pro-inflammatory cytokines such as interleukin-6 (IL-6), TNF-α, and C-reactive protein (CRP) increase adiposity and impair the protein synthesis pathway in skeletal muscles, which promotes the pathogenesis of sarcopenia [9]. Mitochondria dysfunction is associated with sarcopenia because its impairment results in increased reactive oxygen species generation and chronic inflammation [10]. Hormonal changes such as testosterone and estrogen can also influence muscle mass and strength [11].

Although various factors are involved in progression of sarcopenia, the increase of exercise and protein intake are modifiable life factors and a basic strategy to prevent sarcopenia [12]. The current recommended dietary allowance (RDA) of protein is 0.8 g/kg/day, but several studies suggest that higher protein consumption than the RDA is required to preserve muscle mass and function in the elderly [12]. There are concerns about the side effects of protein over intake, which include obesity, kidney disease, gout, and osteoporosis. Therefore, in this review, we summarized recent human clinical studies to understand the type, amount, and duration of protein intake and exercise required to control sarcopenia. The efficacy of amino acid-related supplements normally used in sports nutrition, such as branch-chain amino acid (BCAA), leucine, and β-hydroxy β-methylbutyrate (HMB), have also been discussed for preserving muscle mass and function in the elderly [12]. Moreover, several studies have suggested that consuming multiple combinations of protein, amino acids, and vitamins may be more effective than single protein intake [12]. The combination effect of protein and other supplements has also been described [12]. Research on proteins or supplements that can improve sarcopenia without exercise have been selected first. Studies examining the effect of combination with exercise are cases with protein or supplements that have no effect on improving sarcopenia without exercise, or that have reduced intake dose when combined with exercise.

Protein and Sarcopenia

Studies have reported that protein supplementation did not improve lean body mass nor physical function in older adults. Whey and casein supplement (0.5 g/kg/day, total protein intake: 1.3 g/kg/day) in older adults for 6 months did not increase lean body mass, muscle performance, nor physical function [13]. In addition, 40 g of whey protein isolate supplementation (total protein intake: 1.5 g/kg/day) for 12 weeks, even with resistance exercise in healthy, elderly adults (60-80 years), did not enhance muscle strength and mass [14]. However, the positive effect of milk or whey protein supplementation was investigated in the elderly consuming a low amount of protein under 1.0 g/kg/day [15]. Several studies demonstrated that 1.2-1.5 g/kg/day of milk or whey protein isolate (WPI) with resistance exercise enhanced muscle mass, performance or function in older adults (Table 1). The renal function was not adversely affected up to 1.5 g/kg/day of high protein intake [16]. In case of plant-based protein, soy isolate protein is not less effective than a half dose of WPI [17]. Plant-based protein is generally of lower quality with a lower amino acid profile and reduced bioavailability [18]. Although animal-based protein such as milk protein or WPI is more effective than plant-based protein for overcoming sarcopenia, various sources of plant-based protein should be developed as protein sources for the same goal, as the numbers of vegetarian and environment-related issues continue to increase. Moreover, the effect of protein-based protein on muscle mass and function in the elderly should be investigated since several phytochemicals from plants have been demonstrated to have positive effects on muscle mass and function.

Table 1.

Studies showing positive effect of protein supplementation on sarcopenia.

Protein Subject Amount Total protein intake Duration Exercise Results Ref.
Milk protein Physically active older adults (67-73 years) who were training on a 4-day walking event of 30, 40, 50 km/day with low habitual protein intake (<1.0 g/kg/day) 31 g 1.29 ± 0.28 g/kg/day 12 weeks - Lean body mass ↑
Fat mass ↓
[15]
Whey protein Prefrail and frail malnourished elderly aged 70-85 years (0.8 g/kg/day) 9.3 g whey protein, 0.5g fat, 0.2g cocoa powder 1.5 g/kg/day (1.2 g/kg/day: no significance) 12 weeks - Appendicular skeletal muscle mass, skeletal muscle mass index, gait speed ↑ [19]
Whey protein isolate (WPI) Healthy older men (mean age 67 ±1) 25 g WPI (including~3g leucine) twice directly after breakfast and lunch 1.5 g/kg/day (breakfast 0.45, lunch 0.55, dinner 0.5 g/kg/day) 12 weeks Resistance exercise (RE) twice /week WPI alone: gait speed ↑
RE alone: muscle strength, fat free mass, physical function ↑
No synergistic effects WPI and RE
[16]
Milk protein Mobility-limited older men and women (85±6 years) 34 g of milk protein (17 g protein x 2 times, morning, evening) 1.22 g/kg/day 10 weeks Heavy-load strength training, three times a week Leg lean mass, thickness, knee extensor strength, functional performance ↑ [20]
Milk protein Physically active older men and women (≥65 years) Total 36.8 g milk protein concentrate daily with 31 g protein, 1.1 g fat, 14.5 g lactose, consumed one during breakfast and one within 30 min after exercise 1.35 g/kg/day (Daily protein intake 0.92±0.27 g/kg/day) 12 weeks Trained for 4 day walking event of 30, 40, 50 km/day Lean body mass ↑
Fat mass ↓
[15]
Milk protein concentrate Elderly >60 years Milk protein drink (7.0 g of carbohydrate, 10.1 g of protein and 0.2 g of fat) 1.48 g/kg/day (Daily dietary protein intake is 1.2-1.3 g/kg/day) 6 months Daily exercise training (low-tomoderate intensity) Muscle mass ↑ [21]
Soy protein isolate (SPI) vs. whey protein isolate (WPI) Elderly aged 71±5 years WPI 20, 40 g SPI 20, 40 g WPI, SPI 20 g: 1.28 g/kg/day, WPI 40 g: 1.52 g/kg/day, SPI 40 g: 1.55 g/kg/day (Daily protein intake 1.0 g/kg/day) 1 day Rest or exercise Unilateral kneeextensor resistance exercise Rest+WPI 20 g, 40 g, exercise+WPI 20 g, 40 g, exercise+SPI 40 g: myofibrillar protein fractional synthetic rate ↑
40 g SPI was less effective than 20 g WPI
[17]

Essential Amino Acids (EAAs)

Essential amino acids (EAAs) have been reported to increase muscle protein synthesis (MPS), and especially, a high proportion of leucine is important for optimal stimulation of MPS [22]. However, only a few studies have demonstrated the effect of EAA on muscle mass, strength, and function in older adults [23]. In addition, 8-15 g/day of EAA supplementation for 8 weeks to 18 months enhanced lean body mass or muscle function (Table 2). However, there are few results showing that EAA supplementation increases both muscle mass and function or strength in older adults. A high proportion of leucine in EAA is important for older adults. Also, 41% leucine in EAA is required for optimal stimulation of the rate of MPS in the elderly, although 21% leucine stimulates MPS in young adults [22]. EAA containing 40% leucine only increased both lean body mass and muscle function in the elderly, and EAA containing 20% leucine increased only muscle function [24].

Table 2.

The positive effects of well-known supplements on muscle mass and function in older adults.

Supplement Subject Amount Duration Exercise Results Reference
Essential amino acid (EAA) Elderly patient (75-95 years) with sequelae of coronary artery disease (73%), femoral fracture (34%) 4 g x 2 time = 8 g/day (containing 31% leucine) 8 weeks - Quality of life, muscle function, diet profile ↑ [64]
Healthy older women (68±2 years) 7.5 g x 2 times = 15 g/day (containing 18.6% leucine) 3 months - Lean body mass ↑ [65]
Older adults with sarcopenia (66-84 years 8 g x 2 times =16 g/day (containing 31% leucine) 18 months - Le an body mass ↑ [66]
Older adults (65-75 years) 7.5 g x 2 times =15 g/day (containing 20% or 40% leucine) 12 weeks - Functional performance, lean tissue mass ↑ [24]
Beta-hydroxybeta-methyl butyrate (HMB) Bedridden or sedentary elderly 1.5-3 g 2-24 weeks - Muscle degradation ↓ Strength, function ↑ [34]
Creatine Elderly women (59-90 year) 0.3 g/kg/day 7 days - Sit-to-stand, bench press and leg press, isometric knee extension and flexion, peak power, tandem gait ↑ fat free mass ↑ [43, 67]
Elderly women (mean 65 years old) 0.08 g/kg/day 12 weeks 3 day/week Fat free mass, muscle mass, bench press, knee extension, biceps curl ↑ [68]
Elderly men and women (50-77 year) 0.1 g/kg/day 8 weeks-1 year 3 day/week Leg press strength, lower body strength, muscle thickness, lean tissue mass, bench press, chest press, muscle density ↑ [44, 69]
Fish oil Female, aged 65 years or older, sarcopenic according to the EWGSOP criteria EPA 440 mg, DHA 220 mg 96 days - Muscle strength, performance ↑ [70]
Elderly aged 71.2 years Krill oil 4 g/day (772 mg EPA, 384 mg DHA) 6 months - Knee extensor maximal torque, grip strength, vastus lateralis muscle thickness ↑ [71]
Female aged 60-76 years 5 g/day (2 g EPA, 1g DHA) 12 weeks - Lean mass, timed-upand-to test ↑ [72]
Elderly aged 65 years 2 g/day (~0.4 g/d EPA, 0.3 g/d DHA) 90 days Resistance exercise, 3 times/week for 12 weeks Peak torque and rate of torque development, chair-rising performance ↑ [51]
Citrulline Elderly aged 60-73 years Citrulline-malate 3 g/day 6 weeks - Walking speed ↑ [45, 73]
Malnourished older patients (80-92 years) 10 g 3 weeks - Amino acid availability, lean mass, appendicular skeletal muscle mass ↑ in women Fat mass ↓ in women [46]
Obese elderly (BMI 30-40 kg/m2, HIIT+CIT:67.2±5.0 years, HIIT+placebo: 68.1±4.1 years 10 g 12 weeks High intensity interval training (HITT) Adding citrulline to HIIT: muscle strength ↑ , fat mass ↓ [47]
Vitamin D Pre-sarcopenic, deficient in vitamin D aged 73.31 years 10,000 IU of cholecalciferol 3 times a week for 6 months - Appendicular skeletal muscle mass ↑ [57]

Branch-Chain Amino Acids (BCAAs)

Branch-chain amino acids (BCAAs), such as leucine, isoleucine, and valine, have a branched functional R group and belong to essential amino acid. BCAAs promote the anabolic pathway in muscle rather than the liver [25]. Leucine in particular is a potent activator of mTORC1 and stimulates muscle protein synthesis [26]. mTORC1 promotes protein synthesis and attenuates autophagy by regulating several downstream regulators, such as S6K1, 4E-BP1, and Ulk1 [26]. BCAAs before exercise increased intracellular BCAA levels during exercise and thus inhibit muscle protein breakdown [27]. Therefore, BCAAs are commonly used in sports nutrition. However, there are few studies of BCAA effect on sarcopenia [25]. A recent study showed that 12 g/day of BCAA for 6 months with 30 min exercise did not improve muscle mass in patients with cirrhosis having sarcopenia (protein intake: 1-1.2 g/kg/day) [28]. Supplementation of leucine only is also not promising for preventing sarcopenia [29]. Leucine supplementation (7.5 g/day) for 12 or 24 weeks did not alter lean mass, muscle strength, nor walking speed in healthy, elderly people or type 2 diabetic men [30, 31]. Leucine supplementation (10 g/day) with exercise for 13 weeks only increased walking speed without the increase of lean mass and muscle strength [29].

β-Hydroxy β-Methylbutyrate (HMB)

β-Hydroxy β-methylbutyrate (HMB) is produced by leucine metabolism in the body and has been identified to attenuate sarcopenia by promoting protein synthesis pathway and suppressing proteolysis pathway [32]. Sixty grams daily of leucine is required to make 3 g of HMB to maximally promote muscle protein synthesis, but it is impossible to consume 60 g of leucine per day [32]. Therefore, HMB consumption is more effective than leucine and has been used as a nutritional supplements for athletes to improve muscle mass and performance [33]. Clinical studies of the effect of HMB supplementation on sarcopenia have been well documented recently [34]. In addition, 1.5 g of HMB supplementation during 8 weeks or 24 weeks without exercise improved muscle strength and quality in the elderly [35, 36]. Two grams of HMB supplementation for 2-4 weeks reduced muscle degradation in nursing home residents receiving tube feeding [37]. Meanwhile, 3 g of HMB supplementation for 8 weeks also prevented acute decline in muscle mass in older people with >10 days’ bed rest [38]. It was shown that a daily 2-3 g of HMB consumption is safe without any effect on lipid profile, biochemistry, hepatic, and renal failure [39].

Creatine

Creatine is a nitrogenous organic acid found in red meat, seafood, and poultry and also produced endogenously at about 1 g/day [40, 41]. Approximately 95% of creatine mainly resides in skeletal muscle and a small amount (~5%) of creatine is located in the testes and brain [42]. About 66% of intramuscular creatine is phospho-creatine, and its hydrolysis releases a phosphate group for synthesizing ATP [40]. Therefore, creatine has been used to improve exercise performance in athletes [41]. Many studies regularly showed that creatine supplementation increases strength, lean mass, and muscle morphology with heavy resistance exercise more so than resistance exercise alone [41]. The supplementation of creatine in the elderly also showed a positive effect on muscle mass and performance. When creatine was supplemented to the elderly above 59 years of age without resistance exercise, the effect was shown on muscle mass and function at 0.3 g/kg/day, although a high dose of creatine at 4-20 g/day was also effective [43]. Furthermore, 0.08-0.1 g/kg/day of creatine supplementation with resistance exercise enhances lean body mass, leg density, and exercise performance, such as leg press and chest press strength, suggesting a small amount of creatine is required to overcome sarcopenia with exercise [44]. The study of creatine doses higher than 0.3 g/kg/day on sarcopenia was excluded.

Citrulline

Citrulline is non-essential α-amino acid found in watermelon. It is metabolized to arginine, a key metabolite in nitric oxide synthesis and the urea cycle, and therefore it is recognized as the arginine precursor [45]. Arginine is an essential amino acid that plays an important role in nitric oxide production and the vasolidation process. Arginine is metabolized for excretion through the urea cycle or used for protein synthesis in the rest of tissues [45]. Ten grams of citrulline supplementation in malnourished elderly patients improved amino acid availability in both genders and increased lean mass, appendicular skeletal muscle mass, and decreased fat mass only in women [46]. Other studies also showed that 10 g of citrulline supplementation with high intensity exercise increased muscle strength and decreased fat mass in obese elderly patients compared to an exercise-only group [47]. The combination of citrulline and malate improved walking speed at 3 g, suggesting citrulline malate is an effective form of supplementation. Indeed, 0.18 g/kg citrulline for 7 days does not enhance protein synthesis in healthy people, but the combination of citrulline and malate (8 g) gives beneficial effects such as maximal strength, power, and number of repetitions performed to failure in female athletes [48].

Fish Oil

Chronic low-grade inflammation is associated with aging and therefore involved in the development of sarcopenia [49]. Omega-3 fatty acid (ω-3) has been reported to attenuate sarcopenia due to its anti-inflammatory properties [49]. The effect of ω-3 supplementation on sarcopenia with or without exercise has been well documented recently [50]. Studies showing the positive effects on sarcopenia of low doses of ω-3 supplementation have been mentioned in this section. Supplementation of ω-3 with or without resistance exercise improved muscle strength or function in older adults but does not enhance muscle mass [50]. Also when combined with resistance exercise, even low intake of ω-3 was effective [51].

Vitamin D

Most studies investigating the effect of vitamin D supplementation on sarcopenia have shown that vitamin D-only supplementation did not enhance muscle mass, strength or performance in older adults [52]. For example, approximately 2,000 IU of vitamin D did not reduce the risk of falling in older adults [53]. Also, 3,750 IU of vitamin D improved neither sarcopenia indicators nor adiposity in older adults [54]. High dose of vitamin D supplementation (40,000 IU) did not enhance muscle strength and mass compared to control group in postmenopausal women [55]. A limited number of studies demonstrated an increase in muscle strength in older adults with 25(OH)D ≤ 25 nmol/l [56]. One study showed that vitamin D (10,000 IU) supplementation increased skeletal muscle mass but not muscle strength in pre-sarcopenic older adults with vitamin D deficiency [57].

Combination Effect of Protein and Other Supplements

Whey protein is rich in leucine and effective to counteract sarcopenia as we described in a previous section [58]. Leucine content of protein and essential amino acids are important factors to attenuate sarcopenia although leucine only did not improve sarcopenia factors in older adults [29]. Low vitamin D level is correlated with reduced muscle mass and impaired physical performance in the frail elderly although vitamin D supplementation is not effective on sarcopenia indicators [59]. Therefore, the combination effects of leucine and protein, and vitamin D have been examined. Vitamin D and leucine-rich whey protein enhances lean body mass and muscle function in sarcopenic older adults [60]. Ursolic acid is a phytochemical abundant in apple and has been reported to enhance muscle mass and function in various muscle atrophy animal models [61]. However, recent clinical studies showed that ursolic acid supplementation did not increase muscle strength, mass, serum IGF-1, and Akt-mTORC1 pathway in resistance-trained men [62, 63]. Therefore, the combination of various protein and supplements is a good strategy to counteract sarcopenia rather than one protein or supplement.

Conclusion

As previously described in present study, the effects of protein and supplements on muscle mass and function differed between adults and the elderly. Although the positive effects of protein and supplements were found in adults and athletes, they may not be the same in the elderly. Therefore, further studies on various protein, supplement and pharmaceuticals in sarcopenia should be performed. The RDA of protein for elderly should be revised, and the standard of protein and supplement intake should be reestablished for the elderly. This review could be used as a protein intake guideline for the elderly to attenuate sarcopenia and healthy aging.

Table 3.

Combination effect of protein and other supplements.

Supplement Subject Amount Exercise Duration Results Reference
Whey protein, leucine, vitamin D Older adults (≥65 years) having sarcopenia 12.8 g protein (including 8.5 g of whey protein concentrate), 1.2 g leucine, 120 IU vitamin D, Meal protein intake is 1.2-1.5 g/kg/day, equally distribute their meal time - 12 weeks Gait speed ↑ [74]
Whey protein, leucine, vitamin D Older adults (≥65 years) Twice daily (21 g whey, 3 g leucine, 800 IU vitamin D each serving) or once daily before breakfast - 6-13 weeks Appendicular lean mass ↑ [60, 75, 76]
Whey protein, leucine, vitamin D Older adults (≥65 years) Once daily (22 g whey, 4 g leucine and 100 IU of vitamin D each serving) physical activity (20 min exercise/day, 5 times/week) 12 weeks Fat free mass ↑ Handgrip strength ↑ [77]
Leucine-enriched protein (Casein, whey, soy) vitamin D, calcium Healthy adult (50-80 years) Protein 20 g (casein 50 %+ whey 40 %+ soy 10 %, total leucine 3000 mg), vitamin D 800 IU (20 μg), calcium 300 mg: twice daily (Total protein intake intervention group: ~1.5 g/kg/day, control group: 1.05±0.35 g/kg/day) - 12 weeks Lean body mass/body weight ↑ [78]
Essential amino acid, vitamin D, medium-chain triglyceride Elderly nursing home resident (age of 86.6 years) Essential amino acid 3g (containing L-leucine 1.2 g) and vitamin D (20 μg or 800 IU)-enriched supplement with medium-chain triglyceride 6 g - 3 months Grip strength walking speed, open-and close test performance, peak expiratory flow ↑ [79]
Whey, casein protein, ursolic acid, free BCAA, vitamin D Older adults (>65 years) with (or at risk of) undernutrition Casein 11 g, whey 11 g, free BCAA 7 g, ursolic acid 206 mg, vitamin D3 10.8 μg - 12 weeks Lean body mass, walking performance, mitochondrial function ↑ [80]

Acknowledgments

This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) funded by the Ministry of Agriculture, Food and Rural Affairs (MAFRA) (No. 321023052HD03021782040990000) and a research grant from Seoul Women’s University (2020-0452).

Footnotes

Conflict of Interest

The authors have no financial conflicts of interest to declare.

REFERENCES

  • 1.Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin. Cases Miner. Bone Metab. 2014;11:177–180. doi: 10.11138/ccmbm/2014.11.3.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int. J. Mol. Sci. 2020;21:494. doi: 10.3390/ijms21020494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gao K, Ma WZ, Huck S, Li BL, Zhang L, Zhu J, et al. Association between sarcopenia and depressive symptoms in Chinese older adults: evidence from the China health and retirement longitudinal study. Front. Med (Lausanne). 2021;8:755705. doi: 10.3389/fmed.2021.755705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Xu J, Wan CS, Ktoris K, Reijnierse EM, Maier AB. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68:361–376. doi: 10.1159/000517099. [DOI] [PubMed] [Google Scholar]
  • 5.Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J. Cachexia Sarcopenia Muscle. 2016;7:290–298. doi: 10.1002/jcsm.12073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:B359–365. doi: 10.1093/gerona/57.10.B359. [DOI] [PubMed] [Google Scholar]
  • 7.Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J. Cachexia Sarcopenia Muscle. 2016;7:512–514. doi: 10.1002/jcsm.12147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ziaaldini MM, Marzetti E, Picca A, Murlasits Z. Biochemical pathways of sarcopenia and their modulation by physical exercise: A narrative review. Front. Med. (Lausanne) 2017;4:167. doi: 10.3389/fmed.2017.00167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chhetri JK, de Souto Barreto P, Fougere B, Rolland Y, Vellas B, Cesari M. Chronic inflammation and sarcopenia: a regenerative cell therapy perspective. Exp. Gerontol. 2018;103:115–123. doi: 10.1016/j.exger.2017.12.023. [DOI] [PubMed] [Google Scholar]
  • 10.Coen PM, Musci RV, Hinkley JM, Miller BF. Mitochondria as a target for mitigating sarcopenia. Front. Physiol. 2018;9:1883. doi: 10.3389/fphys.2018.01883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Morley JE. Hormones and Sarcopenia. Curr. Pharm. Des. 2017;23:4484–4492. doi: 10.2174/1381612823666161123150032. [DOI] [PubMed] [Google Scholar]
  • 12.Coelho-Junior HJ, Calvani R, Azzolino D, Picca A, Tosato M, Landi F, et al. Protein intake and sarcopenia in older adults: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2022;19:8178. doi: 10.3390/ijerph19148718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bhasin S, Apovian CM, Travison TG, Pencina K, Moore LL, Huang G, et al. Effect of protein intake on lean body mass in functionally limited older men: a randomized clinical trial. JAMA Intern. Med. 2018;178:530–541. doi: 10.1001/jamainternmed.2018.0008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.de Azevedo Bach S, Radaelli R, Beck Schemes M, Neske R, Garbelotto C, Roschel H, et al. Can supplemental protein to lowprotein containing meals superimpose on resistance-training muscle adaptations in older adults? A randomized clinical trial. Exp. Gerontol. 2022;162:111760. doi: 10.1016/j.exger.2022.111760. [DOI] [PubMed] [Google Scholar]
  • 15.Ten Haaf DSM, Eijsvogels TMH, Bongers C, Horstman AMH, Timmers S, de Groot L, et al. Protein supplementation improves lean body mass in physically active older adults: a randomized placebo-controlled trial. J. Cachexia Sarcopenia Muscle. 2019;10:298–310. doi: 10.1002/jcsm.12394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Griffen C, Duncan M, Hattersley J, Weickert MO, Dallaway A, Renshaw D. Effects of resistance exercise and whey protein supplementation on skeletal muscle strength, mass, physical function, and hormonal and inflammatory biomarkers in healthy active older men: a randomised, double-blind, placebo-controlled trial. Exp. Gerontol. 2022;158:111651. doi: 10.1016/j.exger.2021.111651. [DOI] [PubMed] [Google Scholar]
  • 17.Yang Y, Churchward-Venne TA, Burd NA, Breen L, Tarnopolsky MA, Phillips SM. Myofibrillar protein synthesis following ingestion of soy protein isolate at rest and after resistance exercise in elderly men. Nutr. Metab (Lond). 2012;9:57. doi: 10.1186/1743-7075-9-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Reid-McCann RJ, Brennan SF, McKinley MC, McEvoy CT. The effect of animal versus plant protein on muscle mass, muscle strength, physical performance and sarcopenia in adults: protocol for a systematic review. Syst. Rev. 2022;11:64. doi: 10.1186/s13643-022-01951-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Park Y, Choi JE, Hwang HS. Protein supplementation improves muscle mass and physical performance in undernourished prefrail and frail elderly subjects: a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 2018;108:1026–1033. doi: 10.1093/ajcn/nqy214. [DOI] [PubMed] [Google Scholar]
  • 20.Aas SN, Seynnes O, Benestad HB, Raastad T. Strength training and protein supplementation improve muscle mass, strength, and function in mobility-limited older adults: a randomized controlled trial. Aging Clin. Exp. Res. 2020;32:605–616. doi: 10.1007/s40520-019-01234-2. [DOI] [PubMed] [Google Scholar]
  • 21.Nakayama K, Saito Y, Sanbongi C, Murata K, Urashima T. Effects of low-dose milk protein supplementation following low-tomoderate intensity exercise training on muscle mass in healthy older adults: a randomized placebo-controlled trial. Eur. J. Nutr. 2021;60:917–928. doi: 10.1007/s00394-020-02302-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am. J. Physiol. Endocrinol. Metab. 2006;291:E381–387. doi: 10.1152/ajpendo.00488.2005. [DOI] [PubMed] [Google Scholar]
  • 23.Ispoglou T, Witard OC, Duckworth LC, Lees MJ. The efficacy of essential amino acid supplementation for augmenting dietary protein intake in older adults: implications for skeletal muscle mass, strength and function. Proc. Nutr. Soc. 2021;80:230–242. doi: 10.1017/S0029665120008010. [DOI] [PubMed] [Google Scholar]
  • 24.Ispoglou T, White H, Preston T, McElhone S, McKenna J, Hind K. Double-blind, placebo-controlled pilot trial of L-Leucineenriched amino-acid mixtures on body composition and physical performance in men and women aged 65-75 years. Eur. J. Clin. Nutr. 2016;70:182–188. doi: 10.1038/ejcn.2015.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Le Couteur DG, Solon-Biet SM, Cogger VC, Ribeiro R, de Cabo R, Raubenheimer D, et al. Branched chain amino acids, aging and age-related health. Ageing Res. Rev. 2020;64:101198. doi: 10.1016/j.arr.2020.101198. [DOI] [PubMed] [Google Scholar]
  • 26.Neinast M, Murashige D, Arany Z. Branched chain amino acids. Annu. Rev. Physiol. 2019;81:139–164. doi: 10.1146/annurev-physiol-020518-114455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Shimomura Y, Murakami T, Nakai N, Nagasaki M, Harris RA. Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. J. Nutr. 2004;134:1583S–1587S. doi: 10.1093/jn/134.6.1583S. [DOI] [PubMed] [Google Scholar]
  • 28.Mohta S, Anand A, Sharma S, Qamar S, Agarwal S, Gunjan D, et al. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia. Hepatol. Int. 2022;16:680–690. doi: 10.1007/s12072-022-10334-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Martinez-Arnau FM, Fonfria-Vivas R, Cauli O. Beneficial effects of leucine supplementation on criteria for sarcopenia: A systematic review. Nutrients. 2019;11:2504. doi: 10.3390/nu11102504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Verhoeven S, Vanschoonbeek K, Verdijk LB, Koopman R, Wodzig WK, Dendale P, et al. Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men. Am. J. Clin. Nutr. 2009;89:1468–1475. doi: 10.3945/ajcn.2008.26668. [DOI] [PubMed] [Google Scholar]
  • 31.Leenders M, Verdijk LB, van der Hoeven L, van Kranenburg J, Hartgens F, Wodzig WK, et al. Prolonged leucine supplementation does not augment muscle mass or affect glycemic control in elderly type 2 diabetic men. J. Nutr. 2011;141:1070–1076. doi: 10.3945/jn.111.138495. [DOI] [PubMed] [Google Scholar]
  • 32.Oktaviana J, Zanker J, Vogrin S, Duque G. The Effect of beta-hydroxy-beta-methylbutyrate (HMB) on sarcopenia and functional frailty in older persons: A systematic review. J. Nutr. Health Aging. 2019;23:145–150. doi: 10.1007/s12603-018-1153-y. [DOI] [PubMed] [Google Scholar]
  • 33.Lin Z, Zhao A, He J. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on the muscle strength in the elderly population: A meta-analysis. Front. Nutr. 2022;9:914866. doi: 10.3389/fnut.2022.914866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Costa Riela NA, Alvim Guimaraes MM, Oliveira de Almeida D, Araujo EMQ. Effects of beta-hydroxy-beta-methylbutyrate supplementation on elderly body composition and muscle strength: A review of clinical trials. Ann. Nutr. Metab. 2021;77:16–22. doi: 10.1159/000514236. [DOI] [PubMed] [Google Scholar]
  • 35.Stout JR, Smith-Ryan AE, Fukuda DH, Kendall KL, Moon JR, Hoffman JR, et al. Effect of calcium beta-hydroxy-betamethylbutyrate (CaHMB) with and without resistance training in men and women 65+yrs: a randomized, double-blind pilot trial. Exp. Gerontol. 2013;48:1303–1310. doi: 10.1016/j.exger.2013.08.007. [DOI] [PubMed] [Google Scholar]
  • 36.Ellis AC, Hunter GR, Goss AM, Gower BA. Oral Supplementation with beta-hydroxy-beta-methylbutyrate, arginine, and glutamine improves lean body mass in healthy older adults. J. Diet Suppl. 2019;16:281–293. doi: 10.1080/19390211.2018.1454568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hsieh LC, Chow CJ, Chang WC, Liu TH, Chang CK. Effect of beta-hydroxy-beta-methylbutyrate on protein metabolism in bed-ridden elderly receiving tube feeding. Asia Pac. J. Clin. Nutr. 2010;19:200–208. [PubMed] [Google Scholar]
  • 38.Pereira S, Deutz N, Wolfe R. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on lean body mass during 10 days of bed rest in older adults. Clin. Nutr. 2013;32:659. doi: 10.1016/j.clnu.2013.05.003. [DOI] [PubMed] [Google Scholar]
  • 39.Baier S, Johannsen D, Abumrad N, Rathmacher JA, Nissen S, Flakoll P. Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), L-arginine, and L-lysine. JPEN J. Parenter Enteral. Nutr. 2009;33:71–82. doi: 10.1177/0148607108322403. [DOI] [PubMed] [Google Scholar]
  • 40.Candow DG, Forbes SC, Chilibeck PD, Cornish SM, Antonio J, Kreider RB. Effectiveness of creatine supplementation on aging muscle and bone: focus on falls prevention and inflammation. J. Clin. Med. 2019;8:488. doi: 10.3390/jcm8040488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Cooper R, Naclerio F, Allgrove J, Jimenez A. Creatine supplementation with specific view to exercise/sports performance: an update. J. Int. Soc. Sports Nutr. 2012;9:33. doi: 10.1186/1550-2783-9-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Buford TW, Kreider RB, Stout JR, Greenwood M, Campbell B, Spano M, et al. International society of sports nutrition position stand: creatine supplementation and exercise. J. Int. Soc. Sports Nutr. 2007;4:6. doi: 10.1186/1550-2783-4-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Candow DG, Chilibeck PD, Forbes SC, Fairman CM, Gualano B, Roschel H. Creatine supplementation for older adults: focus on sarcopenia, osteoporosis, frailty and Cachexia. Bone. 2022;162:116467. doi: 10.1016/j.bone.2022.116467. [DOI] [PubMed] [Google Scholar]
  • 44.Bernat P, Candow DG, Gryzb K, Butchart S, Schoenfeld BJ, Bruno P. Effects of high-velocity resistance training and creatine supplementation in untrained healthy aging males. Appl. Physiol. Nutr. Metab. 2019;44:1246–1253. doi: 10.1139/apnm-2019-0066. [DOI] [PubMed] [Google Scholar]
  • 45.Caballero-Garcia A, Pascual-Fernandez J, Noriega-Gonzalez DC, Bello HJ, Pons-Biescas A, Roche E, et al. L-citrulline supplementation and exercise in the management of sarcopenia. Nutrients. 2021;13:3133. doi: 10.3390/nu13093133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Bouillanne O, Melchior JC, Faure C, Paul M, Canoui-Poitrine F, Boirie Y, et al. Impact of 3-week citrulline supplementation on postprandial protein metabolism in malnourished older patients: the ciproage randomized controlled trial. Clin. Nutr. 2019;38:564–574. doi: 10.1016/j.clnu.2018.02.017. [DOI] [PubMed] [Google Scholar]
  • 47.Marcangeli V, Youssef L, Dulac M, Carvalho LP, Hajj-Boutros G, Reynaud O, et al. Impact of high-intensity interval training with or without l-citrulline on physical performance, skeletal muscle, and adipose tissue in obese older adults. J. Cachexia Sarcopenia Muscle. 2022;13:1526–1540. doi: 10.1002/jcsm.12955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Valenzuela PL, Morales JS, Emanuele E, Pareja-Galeano H, Lucia A. Supplements with purported effects on muscle mass and strength. Eur. J. Nutr. 2019;58:2983–3008. doi: 10.1007/s00394-018-1882-z. [DOI] [PubMed] [Google Scholar]
  • 49.Dupont J, Dedeyne L, Dalle S, Koppo K, Gielen E. The role of omega-3 in the prevention and treatment of sarcopenia. Aging Clin. Exp. Res. 2019;31:825–836. doi: 10.1007/s40520-019-01146-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Cornish SM, Cordingley DM, Shaw KA, Forbes SC, Leonhardt T, Bristol A, et al. Effects of omega-3 supplementation alone and combined with resistance exercise on skeletal muscle in older adults: a systematic review and meta-analysis. Nutrients. 2022;14:2221. doi: 10.3390/nu14112221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Rodacki CL, Rodacki AL, Pereira G, Naliwaiko K, Coelho I, Pequito D, et al. Fish-oil supplementation enhances the effects of strength training in elderly women. Am. J. Clin. Nutr. 2012;95:428–436. doi: 10.3945/ajcn.111.021915. [DOI] [PubMed] [Google Scholar]
  • 52.Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D deficiency and sarcopenia in older persons. Nutrients. 2019;11:2861. doi: 10.3390/nu11122861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Waterhouse M, Sanguineti E, Baxter C, Duarte Romero B, McLeod DSA, English DR, et al. Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo-controlled D-health trial. J. Cachexia Sarcopenia Muscle. 2021;12:1428–1439. doi: 10.1002/jcsm.12759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Jabbour J, Rahme M, Mahfoud ZR, El-Hajj Fuleihan G. Effect of high dose vitamin D supplementation on indices of sarcopenia and obesity assessed by DXA among older adults: a randomized controlled trial. Endocrine. 2022;76:162–171. doi: 10.1007/s12020-021-02951-3. [DOI] [PubMed] [Google Scholar]
  • 55.Suebthawinkul C, Panyakhamlerd K, Yotnuengnit P, Suwan A, Chaiyasit N, Taechakraichana N. The effect of vitamin D2 supplementation on muscle strength in early postmenopausal women: a randomized, double-blind, placebo-controlled trial. Climacteric. 2018;21:491–497. doi: 10.1080/13697137.2018.1480600. [DOI] [PubMed] [Google Scholar]
  • 56.Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos. Int. 2011;22:859–871. doi: 10.1007/s00198-010-1407-y. [DOI] [PubMed] [Google Scholar]
  • 57.El Hajj C, Fares S, Chardigny JM, Boirie Y, Walrand S. Vitamin D supplementation and muscle strength in pre-sarcopenic elderly Lebanese people: a randomized controlled trial. Arch. Osteoporos. 2018;14:4. doi: 10.1007/s11657-018-0553-2. [DOI] [PubMed] [Google Scholar]
  • 58.Norton LE, Layman DK. Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. J. Nutr. 2006;136:533S–537S. doi: 10.1093/jn/136.2.533S. [DOI] [PubMed] [Google Scholar]
  • 59.Tieland M, Brouwer-Brolsma EM, Nienaber-Rousseau C, van Loon LJ, De Groot LC. Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur. J. Clin. Nutr. 2013;67:1050–1055. doi: 10.1038/ejcn.2013.144. [DOI] [PubMed] [Google Scholar]
  • 60.Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the provide study: a randomized, double-blind, placebocontrolled trial. J. Am. Med. Dir. Assoc. 2015;16:740–747. doi: 10.1016/j.jamda.2015.05.021. [DOI] [PubMed] [Google Scholar]
  • 61.Rathor R, Agrawal A, Kumar R, Suryakumar G, Singh SN. Ursolic acid ameliorates hypobaric hypoxia-induced skeletal muscle protein loss via upregulating Akt pathway: an experimental study using rat model. IUBMB Life. 2021;73:375–389. doi: 10.1002/iub.2435. [DOI] [PubMed] [Google Scholar]
  • 62.Church DD, Schwarz NA, Spillane MB, McKinley-Barnard SK, Andre TL, Ramirez AJ, et al. l-leucine increases skeletal muscle IGF-1 but does not differentially increase Akt/mTORC1 signaling and serum IGF-1 compared to ursolic acid in response to resistance exercise in resistance-trained men. J. Am. Coll. Nutr. 2016;35:627–638. doi: 10.1080/07315724.2015.1132019. [DOI] [PubMed] [Google Scholar]
  • 63.Lobo PCB, Vieira IP, Pichard C, Marques BS, Gentil P, da Silva EL, et al. Ursolic acid has no additional effect on muscle strength and mass in active men undergoing a high-protein diet and resistance training: A double-blind and placebo-controlled trial. Clin. Nutr. 2021;40:581–589. doi: 10.1016/j.clnu.2020.06.004. [DOI] [PubMed] [Google Scholar]
  • 64.Rondanelli M, Opizzi A, Antoniello N, Boschi F, Iadarola P, Pasini E, et al. Effect of essential amino acid supplementation on quality of life, amino acid profile and strength in institutionalized elderly patients. Clin. Nutr. 2011;30:571–577. doi: 10.1016/j.clnu.2011.04.005. [DOI] [PubMed] [Google Scholar]
  • 65.Dillon EL, Sheffield-Moore M, Paddon-Jones D, Gilkison C, Sanford AP, Casperson SL, et al. Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J. Clin. Endocrinol. Metab. 2009;94:1630–1637. doi: 10.1210/jc.2008-1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, Basso C, et al. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am. J. Cardiol. 2008;101:69E–77E. doi: 10.1016/j.amjcard.2008.03.004. [DOI] [PubMed] [Google Scholar]
  • 67.Gotshalk LA, Volek JS, Staron RS, Denegar CR, Hagerman FC, Kraemer WJ. Creatine supplementation improves muscular performance in older men. Med. Sci. Sports Exerc. 2002;34:537–543. doi: 10.1097/00005768-200203000-00023. [DOI] [PubMed] [Google Scholar]
  • 68.Aguiar AF, Januario RS, Junior RP, Gerage AM, Pina FL, do Nascimento MA, et al. Long-term creatine supplementation improves muscular performance during resistance training in older women. Eur. J. Appl. Physiol. 2013;113:987–996. doi: 10.1007/s00421-012-2514-6. [DOI] [PubMed] [Google Scholar]
  • 69.Candow DG, Little JP, Chilibeck PD, Abeysekara S, Zello GA, Kazachkov M, et al. Low-dose creatine combined with protein during resistance training in older men. Med. Sci. Sports Exerc. 2008;40:1645–1652. doi: 10.1249/MSS.0b013e318176b310. [DOI] [PubMed] [Google Scholar]
  • 70.da Cruz Alves NM, Pfrimer K, Santos PC, de Freitas EC, Neves T, Pessini RA, et al. Randomised controlled trial of fish oil supplementation on responsiveness to resistance exercise training in sarcopenic older women. Nutrients. 2022;14:2844. doi: 10.3390/nu14142844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Alkhedhairi SA, Aba Alkhayl FF, Ismail AD, Rozendaal A, German M, MacLean B, et al. The effect of krill oil supplementation on skeletal muscle function and size in older adults: a randomised controlled trial. Clin. Nutr. 2022;41:1228–1235. doi: 10.1016/j.clnu.2022.04.007. [DOI] [PubMed] [Google Scholar]
  • 72.Logan SL, Spriet LL. Omega-3 fatty acid supplementation for 12 weeks increases resting and exercise metabolic rate in healthy community-dwelling older females. PLoS One. 2015;10:e0144828. doi: 10.1371/journal.pone.0144828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Perez-Guisado J, Jakeman PM. Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. J. Strength Cond. Res. 2010;24:1215–1222. doi: 10.1519/JSC.0b013e3181cb28e0. [DOI] [PubMed] [Google Scholar]
  • 74.Lin CC, Shih MH, Chen CD, Yeh SL. Effects of adequate dietary protein with whey protein, leucine, and vitamin D supplementation on sarcopenia in older adults: an open-label, parallel-group study. Clin. Nutr. 2021;40:1323–1329. doi: 10.1016/j.clnu.2020.08.017. [DOI] [PubMed] [Google Scholar]
  • 75.Cereda E, Pisati R, Rondanelli M, Caccialanza R. Whey protein, leucine- and Vitamin-D-enriched oral nutritional supplementation for the treatment of sarcopenia. Nutrients. 2022;14:1524. doi: 10.3390/nu14071524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Chanet A, Verlaan S, Salles J, Giraudet C, Patrac V, Pidou V, et al. Supplementing breakfast with a Vitamin D and leucineenriched whey protein medical nutrition drink enhances postprandial muscle protein synthesis and muscle mass in healthy older men. J. Nutr. 2017;147:2262–2271. doi: 10.3945/jn.117.252510. [DOI] [PubMed] [Google Scholar]
  • 77.Rondanelli M, Klersy C, Terracol G, Talluri J, Maugeri R, Guido D, et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am. J. Clin. Nutr. 2016;103:830–840. doi: 10.3945/ajcn.115.113357. [DOI] [PubMed] [Google Scholar]
  • 78.Kang Y, Kim N, Choi YJ, Lee Y, Yun J, Park SJ, et al. Leucine-enriched protein supplementation increases lean body mass in healthy korean adults aged 50 years and older: a randomized, double-blind, placebo-controlled trial. Nutrients. 2020;12:1816. doi: 10.3390/nu12061816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Abe S, Ezaki O, Suzuki M. Medium-chain triglycerides in combination with leucine and Vitamin D increase muscle strength and function in frail elderly adults in a randomized controlled trial. J. Nutr. 2016;146:1017–1026. doi: 10.3945/jn.115.228965. [DOI] [PubMed] [Google Scholar]
  • 80.Grootswagers P, Smeets E, Oteng AB, Groot L. A novel oral nutritional supplement improves gait speed and mitochondrial functioning compared to standard care in older adults with (or at risk of) undernutrition: results from a randomized controlled trial. Aging (Albany NY) 2021;13:9398–9418. doi: 10.18632/aging.202912. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Microbiology and Biotechnology are provided here courtesy of Korean Society for Microbiology and Biotechnology

RESOURCES